NPI: 1710439187 · INDIO, CA 92203 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/01/2016
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/01/2016 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 2,708 | $135K |
| 2020 | 5,878 | $171K |
| 2021 | 9,099 | $374K |
| 2022 | 10,406 | $467K |
| 2023 | 12,297 | $621K |
| 2024 | 8,749 | $618K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,429 | 1,572 | $2.34M |
| A4657 | Syringe, with or without needle, each | 1,026 | 740 | $26K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,418 | 1,002 | $15K |
| 0250 | 3,344 | 228 | $849.29 | |
| J1756 | Injection, iron sucrose, 1 mg | 4,283 | 1,043 | $257.49 |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,602 | 326 | $134.57 |
| 85041 | 710 | 613 | $2.67 | |
| 85048 | 630 | 550 | $2.28 | |
| 83970 | 501 | 445 | $0.00 | |
| 83540 | 223 | 217 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 509 | 292 | $0.00 |
| 82108 | 15 | 15 | $0.00 | |
| 83550 | 170 | 165 | $0.00 | |
| 82728 | 192 | 191 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 70 | 43 | $0.00 |
| 90674 | 15 | 13 | $0.00 |